SAN FRANCISCO, CA – October 31, 2013 – According to a recent study of diabetic patients who underwent revascularization for multi-vessel coronary artery disease (CAD), patients treated with insulin experienced more major adverse cardiovascular events after revascularization than those not treated with insulin.
Culture
Attracting more talented foreign students to study at U.S. universities and encouraging them to launch entrepreneurial ventures here could help "revitalize innovation and economic growth" in this country, a trio of economists led by University of Colorado Boulder Professor Keith Maskus concludes.
Maskus and co-authors Ahmed Mushfiq Mobarak, associate professor at the Yale School of Management, and Eric T. Stuen, assistant professor at the University of Idaho College of Business and Economics, make this case in the Policy Forum of the Nov. 1 edition of the journal Science.
Knowing who your doctor is — and a couple of facts about that person — may go a long way toward improving patient satisfaction, according to a Vanderbilt study in the Journal of Orthopaedic Trauma.
Faced with the knowledge that between 82 percent and 90 percent of medical patients are unable to correctly name their treating physician following inpatient admission, orthopaedic trauma surgeon Alex Jahangir, M.D., and his Vanderbilt colleagues studied the effects of giving a randomized group of patients a simple biosketch card about their doctor.
BLOOMINGTON, Ind. -- A new paper by an Indiana University professor sheds new light on the U.S. Supreme Court's rejection of legal challenges to the Affordable Care Act, which many critics said threatens state sovereignty and individual liberties.
The paper comes at a time when problems with the act's implementation, particularly the creation of state health care exchanges, highlight the limits of federal capabilities and the importance of state cooperation in the success of domestic government programs.
SAN FRANCISCO, CA – October 31, 2013 – According to a new study, patients that do not experience a major cardiac event in the first year after receiving drug-eluting stent (DES) may not need to receive prolonged dual antiplatelet therapy (DAPT). Results from the ARCTIC-INTERRUPTION trial were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.
Being left-handed has been linked to many mental disorders, but Yale researcher Jadon Webb and his colleagues have found that among those with mental illnesses, people with psychotic disorders like schizophrenia are much more likely to be left-handed than those with mood disorders like depression or bipolar syndrome.
The new study is published in the October-December 2013 issue of the journal SAGE Open.
SAN FRANCISCO, CA – OCTOBER 31, 2013 - A new study demonstrates that some patients may not need to receive prolonged anti-clotting therapy after drug-eluting stent (DES) implantation with the Endeavor zotarolimus-eluting stent, and that shortening the duration could reduce bleeding risks and treatment costs. The OPTIMIZE clinical trial findings were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
ST. LOUIS – Opioid analgesics, or prescription-based narcotic pain killers, have long been known to reduce pain, but reports of adverse effects and addiction continue to surface. Now, a team of investigators led by a Saint Louis University researcher has discovered a link between chronic use of pain-relieving medication and increase in the risk of developing major depression.
DETROIT – More than half of chronic hepatitis C patients studied in a new research project led by Henry Ford Hospital were not treated for the potentially fatal disease, either because they couldn't withstand current therapies or because they, or their doctors, were waiting for new treatments.
In a second, related study, Henry Ford researchers found that while the disease is not yet curable, there is a significant "lost opportunity" for hepatitis C patients to achieve the current best result of treatment.
BOSTON – Contrary to popular myth, it is not the aging Baby Boomer or weekend warrior that is causing the unprecedented increase in knee replacement surgeries. Data gathered by more than 125 orthopedic surgeons from 22 states across the U.S. show a more mundane culprit: rising rates of obesity among those under the age of 65.
The risks of developing kidney failure and a calcium deficiency from the popular osteoporosis drug zoledronic acid are extremely rare, according to researchers at Loyola University Health System (LUHS). These findings were presented earlier this month at the American Society for Bone and Mineral Research's annual meeting.
SAN FRANCISCO, CA – OCTOBER 30, 2013 – A clinical trial shows that rapidly cooling patients who have suffered ST-elevation myocardial infarction (STEMI, the most serious form of a heart attack) prior to restoring blood flow is safe and feasible. The findings of the CHILL-MI trial were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.
WASHINGTON, D.C., October 31, 2013 --New research from the Strategies to Overcome and Prevent (STOP) Obesity Alliance sheds light on the challenges and opportunities for nonprofit hospitals to address obesity through community benefit activities. With obesity affecting more than one-third of adults and 17 percent of children in the United States, many communities are facing the challenge of how to address this epidemic. Nonprofit hospitals are uniquely positioned to help through their ongoing efforts to provide community benefit programs.
SAN FRANCISCO, CA – October 30, 2013 – A new study supports the use of instantaneous wave-free ratio (iFR), to simplify assessment and determine the severity of coronary artery disease. ADVISE II findings were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.
SAN FRANCISCO, CA – October 30, 2013 – A new study shows that a conservative approach to revascularization for patients with intermediate coronary lesions determined by angiographic diameter stenosis is safe and non-inferior to an aggressive approach. Findings of the SMART-CASE trial were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.